financetom
Business
financetom
/
Business
/
L3Harris Technologies Q3 Non-GAAP EPS, Sales Rise; Guidance Narrowed -- Shares Up After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
L3Harris Technologies Q3 Non-GAAP EPS, Sales Rise; Guidance Narrowed -- Shares Up After Hours
Nov 3, 2024 11:10 AM

04:48 PM EDT, 10/24/2024 (MT Newswires) -- L3Harris Technologies ( LHX ) reported Q3 non-GAAP earnings late Thursday of $3.34 per diluted share, up from $3.19 a year earlier.

Analysts polled by Capital IQ expected $3.26.

Revenue for the quarter ended Sept. 27 was $5.29 billion, up from $4.92 billion a year earlier.

Analysts surveyed by Capital IQ expected $5.28 billion.

The company expects full-year 2024 non-GAAP earnings of $12.95 to $13.15 per diluted share, versus its prior forecasts of $12.85 to $13.15 per diluted share. Analysts surveyed by Capital IQ expect $13.04.

The company expects revenue for the full year of $21.1 billion to $21.3 billion, compared with its previous projections of $21 billion to $21.3 billion. Analysts polled by Capital IQ expect $21.25 billion.

Shares traded 4% higher in after-hours activity.

Price: 254.85, Change: +10.68, Percent Change: +4.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
L3Harris Technologies Q3 Non-GAAP EPS, Sales Rise; Guidance Narrowed -- Shares Up After Hours
L3Harris Technologies Q3 Non-GAAP EPS, Sales Rise; Guidance Narrowed -- Shares Up After Hours
Nov 3, 2024
04:48 PM EDT, 10/24/2024 (MT Newswires) -- L3Harris Technologies ( LHX ) reported Q3 non-GAAP earnings late Thursday of $3.34 per diluted share, up from $3.19 a year earlier. Analysts polled by Capital IQ expected $3.26. Revenue for the quarter ended Sept. 27 was $5.29 billion, up from $4.92 billion a year earlier. Analysts surveyed by Capital IQ expected $5.28...
ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices
ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices
Nov 3, 2024
Oct 24 (Reuters) - ResMed ( RMD ) beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment. Shares of the company rose about 4% in after-hours trading. The San Diego, California-based company posted adjusted profit of $2.20 per share for the quarter ended September 30, beating estimates of...
--L3Harris Technologies CEO Expects to Reach Overall Savings Target of $1 Billion One Year Early
--L3Harris Technologies CEO Expects to Reach Overall Savings Target of $1 Billion One Year Early
Nov 3, 2024
04:50 PM EDT, 10/24/2024 (MT Newswires) -- Price: 254.50, Change: +10.33, Percent Change: +4.23 ...
Quikrete is in talks to acquire Summit Materials, sources say
Quikrete is in talks to acquire Summit Materials, sources say
Nov 3, 2024
NEW YORK (Reuters) - Building materials provider Quikrete has approached rival Summit Materials ( SUM ), which has a market value of more than $7 billion, with an acquisition offer, people familiar with the matter said on Thursday. Quikrete, which is privately held, is working with its advisers on the bid for Summit Materials ( SUM ) and the talks...
Copyright 2023-2025 - www.financetom.com All Rights Reserved